These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 2751)

  • 41. Drug-binding properties of rat alpha-foetoprotein. Specificities of the phenylbutazone-binding and warfarin-binding sites.
    Hervé F; Rajkowski KM; Martin MT; Dessen P; Cittanova N
    Biochem J; 1986 Oct; 239(2):451-8. PubMed ID: 2434073
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Spectrophotofluorometric evidence of negatively cooperative binding of warfarin and phenylbutazone to human serum albumin.
    Madsen BW; Tearne PD
    Life Sci; 1980 Jan; 26(3):173-9. PubMed ID: 7360001
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of mucin on the bioavailability of tetracycline from the gastrointestinal tract; in vivo, in vitro correlations.
    Braybrooks MP; Barry BW; Abbs ET
    J Pharm Pharmacol; 1975 Jul; 27(7):508-15. PubMed ID: 239156
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Drug permeation through membranes. 3. Effect of pH and various substances on permeation of phenylbutazone through everted rat intestine and polydimethylsiloxane.
    Lovering EG; Black DB
    J Pharm Sci; 1974 May; 63(5):671-6. PubMed ID: 4829985
    [No Abstract]   [Full Text] [Related]  

  • 45. Influence of allopurinol on drug metabolism in man.
    Rawlins MD; Smith SE
    Br J Pharmacol; 1973 Aug; 48(4):693-8. PubMed ID: 4788211
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The interaction of warfarin with antacid constituents in the gut.
    McElnay JC; Harron DW; D'Arcy PF; Collier PS
    Experientia; 1979 Oct; 35(10):1359-60. PubMed ID: 499421
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Application of stable labelled drugs in clinical pharmacokinetic investigations.
    Eichelbaum M; von Unruh GE; Somogyi A
    Clin Pharmacokinet; 1982; 7(6):490-507. PubMed ID: 6819104
    [No Abstract]   [Full Text] [Related]  

  • 48. Mechanism of the intestinal absorption of drugs from oil in water emulsions. IV. Absorption from emulsions containing the higher concentration of emulsifier.
    Ogata H; Kakemi K; Muranishi S; Sezaki H
    Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):707-15. PubMed ID: 1182858
    [No Abstract]   [Full Text] [Related]  

  • 49. The absorption of warfarin from the rat small intestine in situ.
    Julkunen RJ
    J Pharm Pharmacol; 1976 Jun; 28(6):493-7. PubMed ID: 7646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Numerical solution of nonlinear pharmacokinetic equations: effects of plasma protein binding on drug distribution and elimination.
    Coffey JJ; Bullock FJ; Schoenemann PT
    J Pharm Sci; 1971 Nov; 60(11):1623-8. PubMed ID: 5133908
    [No Abstract]   [Full Text] [Related]  

  • 51. Bioavailability of 'bute'.
    Vet Rec; 1983 Jun; 112(26):595. PubMed ID: 6879986
    [No Abstract]   [Full Text] [Related]  

  • 52. Interaction of drugs with bile components. II. Effect of bile on the absorption of indomethacin and phenylbutazine in rats.
    Miyazaki S; Yamahira T; Inoue H; Nadai T
    Chem Pharm Bull (Tokyo); 1980 Jan; 28(1):323-6. PubMed ID: 7363376
    [No Abstract]   [Full Text] [Related]  

  • 53. Absorption of two tyrosine containing tri-peptides from the small intestine and rectum of the rat [proceedings].
    Heading CE; Rogers CS; Wilkinson S
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():39P. PubMed ID: 42713
    [No Abstract]   [Full Text] [Related]  

  • 54. Phenylbutazone.
    DiSanto AR
    J Am Pharm Assoc; 1976 Jun; 16(6):365-8. PubMed ID: 1270744
    [No Abstract]   [Full Text] [Related]  

  • 55. The influence of mucin on the bioavailability of tetracycline.
    Kellaway IW; Marriot C
    J Pharm Pharmacol; 1975 Apr; 27(4):281-3. PubMed ID: 239124
    [No Abstract]   [Full Text] [Related]  

  • 56. [Structure and properties of gastric mucin].
    Gindzieński A; Zwierz K
    Postepy Hig Med Dosw; 1978; 32(2):265-75. PubMed ID: 568258
    [No Abstract]   [Full Text] [Related]  

  • 57. Proceedings: A mucin model for the in vitro evaluation of mucolytic agents.
    Davis SS; Inglis A; McNeil D; Scobie S
    J Pharm Pharmacol; 1974 Dec; 26 Suppl():64P. PubMed ID: 4156743
    [No Abstract]   [Full Text] [Related]  

  • 58. A drug absorption model based on the mucus layer producing human intestinal goblet cell line HT29-H.
    Wikman A; Karlsson J; Carlstedt I; Artursson P
    Pharm Res; 1993 Jun; 10(6):843-52. PubMed ID: 8321852
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceedings: Influence of a mucin model system upon the bioavailability of phenylbutazone and warfarin sodium from the small intestine.
    Barry BW; Braybrooks MP
    J Pharm Pharmacol; 1975 Dec; 27 Suppl?-2():74P. PubMed ID: 2751
    [No Abstract]   [Full Text] [Related]  

  • 60. A model solution for intestinal absorption of warfarin. A drug with non-linear distribution pharmacokinetics in the rat.
    Julkunen RJ; Kekki M; Wahlström B
    Arzneimittelforschung; 1980; 30(2):264-7. PubMed ID: 7378103
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.